News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDAAdvisoryCommittee.com To Webcast Dec. 1-2 Reviews Of Procter & Gamble's (PG) Sexual Dysfunction Drug Intrinsa, ILEX Oncology, Inc.' (ILXO) Clolar For Leukemia, And INEX Pharmaceuticals (IEX.TO) / Enzon Pharmaceuticals, Inc.'s (ENZN) Marqibo For Lymphoma



10/19/2005 5:12:19 PM

Breakthrough FDAAdvisoryCommittee.com Webcasts on Dec 1-2 will provide live audio/video access to Food and Drug Administration committee reviews of three new drugs: Ilex' Clolar (Leukemia), Inex/Enzon's Marqibo (Hodgkin's Lymphoma); and Proctor & Gamble's Intrinsa (female sexual dysfunction).

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES